CNS Pharmaceuticals financial statements

CNS 파머슈티컬스NASDAQ:CNSP · Nasdaq · Healthcare · sector #17
$5.43+2.42%
2026-10-07 close · prelim

CNS Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$15M.

Reported results

CNS Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy